A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

Clinical trial NCT05530655 · RECRUITING

Trial details

NCT number: NCT05530655
Sponsor: University of Rochester
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Radiation Toxicity Urinary Complication

Start date: 2024-02-20
Primary completion: 2028-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.